Does the use of the checkpoint inhibitor nivolumab affect the outcomes of transplant?
Carmelo Carlo Stella
Proton and photon therapy in managing hematological malignancies
New aims and next steps for adult ALL induction therapy
The origin and work of the International Workshop on Chronic Lymphocytic Leukemia (iwCLL)
Multiple myeloma highlights from ASCO 2016: monoclonal antibodies and oral proteasome inhibitors